Brief: Volitionrx Ltd Signs MOU With Fosun Long March In China
28/03/2019 12:41
March 28 (Reuters) - VolitionRX Ltd VNRX.A :
* VOLITIONRX LIMITED SIGNS MEMORANDUM OF UNDERSTANDING WITH
FOSUN
LONG MARCH IN CHINA
* VOLITIONRX LTD - PARTIES INTEND TO CONDUCT THREE CLINICAL
STUDIES IN CHINA IN COLORECTAL CANCER, LUNG CANCER AND OVARIAN
CANCER
Source text for Eikon: ID:nPn5YD6rCa
Further company coverage: VNRX.A
(Reuters.Briefs@thomsonreuters.com)
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems